
ALT A line graph compares the cumulative hazard of a primary-outcome event over five years between standard and intensive treatments. The intensive treatment line is in blue, and the standard treatment line is in gray. An inset chart displays the hazard ratio as 0.79 with a 95% confidence interval of 0.67 to 0.94, and a p-value of 0.007. Below the graph, a table shows the number at risk for each treatment over time.

ALT This image is a forest plot compares intensive treatment versus standard treatment across various subgroups. The chart shows hazard ratios for primary outcomes, with confidence intervals. Subgroups include age, race, diabetes, chronic kidney disease, blood pressure levels, body-mass index, prior cardiovascular disease, and qualifying event. The hazard ratios and confidence intervals are displayed along a horizontal axis, indicating whether intensive or standard treatment is better.

ALT This image is a slide detailing information from a study titled "OPTIMAL-STROKE: Intensive Blood-Pressure Control in Patients with Previous Ischemic Stroke." The slide includes the objective, study design, and conclusions. The study aims to investigate intensive blood pressure control's effect on cardiovascular risk after cerebrovascular events, with a design of an open-label, randomized study involving 4,368 participants. Results suggest that targeting a systolic BP of less than 120 mm Hg lowers the incidence of major cardiovascular events compared to 140 mm Hg in patients with previous ischemic stroke or transient ischemic attack. The logo of the American Heart Association is in the bottom left corner.

ALT A graph from the Original Article "Intensive Blood-Pressure Control in Patients with Previous Ischemic Stroke.” The trial name, OPTIMAL-STROKE, is in parentheses after the title. The graph shows the cumulative hazard of the primary outcome. The trial results are being presented at the American Heart Association Scientific Sessions 2026. The logo of the New England Journal of Medicine is at the bottom.




















